New non-viral method for gene transfer into primary cells

被引:180
|
作者
Gresch, O
Engel, FB
Nesic, D
Tran, TT
England, HM
Hickman, ES
Körner, I
Gan, L
Chen, S
Castro-Obregon, S
Hammermann, R
Wolf, J
Müller-Hartmann, H
Nix, M
Siebenkotten, G
Kraus, G
Lun, K
机构
[1] Amaxa GmbH, D-50829 Cologne, Germany
[2] Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany
[3] Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Cell Biol,Dept Cardio, Boston, MA 02115 USA
[4] Univ Bern, Inst Pathol, CH-3010 Bern, Switzerland
[5] Novartis Inst Biomed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England
[6] Humboldt Univ, Robert Rossle Klin, Dept Hematol Oncol & Tumorimmunol, D-13125 Berlin, Germany
[7] AGY Therapeut, San Francisco, CA 94080 USA
[8] Buck Inst Age Res, Novato, CA 94945 USA
关键词
nucleofection; Transfection; non-viral gene transfer; siRNA; CLL; lymphocytes; CD34+cells; cardiomyocytes; chondrocytes; neurons;
D O I
10.1016/j.ymeth.2003.11.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The availability of genetically altered cells is an essential prerequisite for many scientific and therapeutic applications including functional genomics, drug development, and gene therapy. Unfortunately, the efficient gene transfer into primary cells is still problematic. In contrast to transfections of most cell lines, which can be successfully performed using a variety of methods, the introduction of foreign DNA into primary cells requires a careful selection of gene transfer techniques. Whereas viral strategies are time consuming and involve safety risks, non-viral methods proved to be inefficient for most primary cell types. The Nucleofector technology is a novel gene transfer technique designed for primary cells and hard-to-transfect cell lines. This non-viral gene transfer method is based on a cell type specific combination of electrical parameters and solutions. In this report, we show efficient transfer of DNA expression vectors and siRNA oligonucleotides into a variety of primary cell types from different species utilizing the Nucleofector technology, including human B-CLL cells, human CD34+ cells, human lymphocytes, rat cardiomyocytes, human, porcine, and bovine chondrocytes, and rat neurons. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:151 / 163
页数:13
相关论文
共 50 条
  • [31] Efficient non-viral gene delivery to primary, leukemia B cells by mRNA transfection
    Li, LH
    Allen, C
    Shivakumar, R
    Weiss, JM
    Fratantoni, JC
    Liu, LN
    MOLECULAR THERAPY, 2004, 9 : S220 - S220
  • [32] Muscle gene transfer mediated by mesoangioblasts and non-viral vectors
    Iyer, Pavithra S.
    van Zwieten, Ruthger
    Ley, Deborah
    Mermod, Nicolas
    HUMAN GENE THERAPY, 2014, 25 (11) : A73 - A73
  • [33] Non-Viral Ocular Gene Transfer for Hereditary Retinal Degeneration
    Naash, Muna I.
    Ballard, Ron M.
    Skaggs, Jeff
    Nash, Zack
    Quiambao, Alexander B.
    Cooper, Mark J.
    Farjo, Rafal
    MOLECULAR THERAPY, 2006, 13 : S340 - S340
  • [34] A novel non-viral gene transfer system, polycation liposomes
    Oku, N
    Yamazaki, Y
    Matsuura, M
    Sugiyama, M
    Hasegawa, M
    Nango, M
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (03) : 209 - 218
  • [35] Chemical enhancers of non-viral salivary gland gene transfer
    McMahon, BM
    Chen, YJ
    Niedzinski, EJ
    Bennett, MJ
    MOLECULAR THERAPY, 2004, 9 : S57 - S57
  • [36] Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer
    Wagstaff, Kylie M.
    Jans, David A.
    BIOCHEMICAL JOURNAL, 2007, 406 (02) : 185 - 202
  • [37] Non-viral methods for gene transfer towards osteosarcoma therapy
    Dass, Crispin R.
    Choong, Peter F. M.
    JOURNAL OF DRUG TARGETING, 2007, 15 (03) : 184 - 189
  • [38] Peptide-mediated non-viral gene transfer for transplantation
    George, AJT
    TRANSPLANTATION, 2000, 69 (06) : 1031 - 1033
  • [39] Non-viral gene transfer using integrating vector systems
    Izsvak, Suzanna
    HUMAN GENE THERAPY, 2009, 20 (11) : 1356 - 1357
  • [40] Targeted gene transfer to proliferating endothelium: viral versus non-viral approaches
    Freudenthaler, H.
    Kuepcue, S.
    Gornikiewicz, A.
    Zommer, A.
    Sara, M.
    Sleytr, U.
    Brostjan, C.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1471 - 1472